Cite

HARVARD Citation

    Bauché, D. et al. (2020). Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions. Journal for immunotherapy of cancer. 8 (2), p. . [Online]. 
  
Back to record